Endotoxin/Lipopolysaccharide Activates NF-κB and Enhances Tumor Cell Adhesion and Invasion Through a β1 Integrin-Dependent Mechanism
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
β1 integrins play a crucial role in supporting tumor cell attachment to and invasion into the extracellular matrix. Endotoxin/LPS introduced by surgery has been shown to enhance tumor metastasis in a murine model. Here we show the direct effect of LPS on tumor cell adhesion and invasion in extracellular matrix proteins through a β1 integrin-dependent pathway. The human colorectal tumor cell lines SW480 and SW620 constitutively expressed high levels of the β1 subunit, whereas various low levels of α1, α2, α4, and α6 expression were detected. SW480 and SW620 did not express membrane-bound CD14; however, LPS in the presence of soluble CD14 (sCD14) significantly up-regulated β1 integrin expression; enhanced tumor cell attachment to fibronectin, collagen I, and laminin; and strongly promoted tumor cell invasion through the Matrigel. Anti-β1 blocking mAbs (4B4 and 6S6) abrogated LPS- plus sCD14-induced tumor cell adhesion and invasion. Furthermore, LPS, when combined with sCD14, resulted in NF-κB activation in both SW480 and SW620 cells. Inhibition of the NF-κB pathway significantly attenuated LPS-induced up-regulation of β1 integrin expression and prevented tumor cell adhesion and invasion. These results provide direct evidence that although SW480 and SW620 cells do not express membrane-bound CD14, LPS in the presence of sCD14 can activate NF-κB, up-regulate β1 integrin expression, and subsequently promote tumor cell adhesion and invasion. Moreover, LPS-induced tumor cell attachment to and invasion through extracellular matrix proteins is β1 subunit-dependent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262 · cited 1×
“It has been found that overexpression of integrin v 3 correlates with aggressive phenotypes in different malignancies and with tumor angiogenesis (51, 52).”
BackgroundToll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442 · cited 1×
“Over the years many LPS-binding proteins have been identified (42).”
BackgroundKawahara, K., Tsukano, H., Watanabe, H., Lindner, B., & Matsuura, M. (2002) · Infection and Immunity · doi:10.1128/iai.70.8.4092-4098.2002 · Cited by 246 · cited 1×
“Although we cannot completely exclude the possibility that LPS used in this study was contaminated with nonLPS bacterial cell wall components, it must be pointed out that LPS from any bacterial species is a mixture of different LPS, which may elicit distinct biological effects (63, 64), and that repurification of LPS…”
BackgroundThe role of NF-κB/IκB proteins in cancer: implications for novel treatment strategies
Schwartz, S. A., Hernandez, A., & Mark Evers, B. (1999) · Surgical Oncology · doi:10.1016/s0960-7404(00)00012-8 · Cited by 132 · cited 1×
“Constitutive activation of NF- B has been described in a number of tumor cells, and appears to be associated with continued cytokine production, inhibition of apoptosis, activation of cell cycle, and possibly tumor progression (56).”
Background
Cited by
Toll-like receptors and cancer
Rakoff-Nahoum, S., & Medzhitov, R. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2541 · Cited by 925
Thomson, N. C., Chaudhuri, R., & Livingston, E. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00039004 · Cited by 555
Cigarette Smoking Impairs the Therapeutic Response to Oral Corticosteroids in Chronic Asthma
Chaudhuri, R., Livingston, E., McMahon, A. D., Thomson, L., Borland, W., & Thomson, N. C. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-503oc · Cited by 470
TLR signaling by tumor and immune cells: a double-edged sword
Huang, B., Zhao, J., Unkeless, J. C., Feng, Z. H., & Xiong, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210904 · Cited by 377
Excisional surgery for cancer cure: therapy at a cost
Coffey, J., Wang, J., Smith, M., Bouchier-Hayes, D., Cotter, T., & Redmond, H. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01282-8 · Cited by 374
Self-citationHe, W., Liu, Q., Wang, L., Chen, W., Li, N., & Cao, X. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.01.022 · Cited by 340
Toll-like receptors in inflammation, infection and cancer
Chen, K., Huang, J., Gong, W., Iribarren, P., Dunlop, N. M., & Wang, J. M. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.05.016 · Cited by 327
Self-citationToyoshima, F., & Nishida, E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601599 · Cited by 264
Szczepanski, M. J., Czystowska, M., Szajnik, M., Harasymczuk, M., Boyiadzis, M., Kruk-Zagajewska, A., Szyfter, W., Zeromski, J., & Whiteside, T. L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3838 · Cited by 253
McDonald, B., Spicer, J., Giannais, B., Fallavollita, L., Brodt, P., & Ferri, L. E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24409 · Cited by 222
Bacterial contamination hypothesis: a new concept in endometriosis
Khan, K. N., Fujishita, A., Hiraki, K., Kitajima, M., Nakashima, M., Fushiki, S., & Kitawaki, J. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12083 · Cited by 176
Jing, Y.-Y., Han, Z.-P., Sun, K., Zhang, S.-S., Hou, J., Liu, Y., Li, R., Gao, L., Zhao, X., Zhao, Q.-D., et al. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-98 · Cited by 162
TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings
Shetab Boushehri, M. A., & Lamprecht, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00691 · Cited by 161
Biomimetic Model of Tumor Microenvironment on Microfluidic Platform
Chung, M., Ahn, J., Son, K., Kim, S., & Jeon, N. L. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700196 · Cited by 126
Metadata
- Authors
- Wang, J. H., Manning, B. J., Wu, Q. D., Blankson, S., Bouchier-Hayes, D., & Redmond, H. P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-01
- Volume
- 170
- Issue
- 2
- Pages
- 795-804
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1568959328
- Cited by
- 139
- References
- 6
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.